We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Unisys
UIS
$210M
| $1.96M | ﹤0.01% |
165,462
+8,168
| +5% | +$81.9K |
|
|
SC
1802
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.96M | ﹤0.01% |
83,892
-85
| -0.1% | -$2.06K |
|
|
NVTA
1803
DELISTED
Invitae Corporation
NVTA
| $1.95M | ﹤0.01% |
120,785
+5,202
| +5% | +$92K |
|
1804
WisdomTree
WT
$3.26B
| $1.95M | ﹤0.01% |
401,880
+17,132
| +4% | +$85K |
|
|
ECHO
1805
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.94M | ﹤0.01% |
93,851
+4,382
| +5% | +$91.5K |
|
1806
First Bancorp
FBNC
$2.66B
| $1.94M | ﹤0.01% |
48,617
+659
| +1% | +$25.2K |
|
1807
Cooper-Standard Automotive
CPS
$491M
| $1.93M | ﹤0.01% |
58,333
+2,944
| +5% | +$95.4K |
|
|
ATSG
1808
DELISTED
Air Transport Services Group
ATSG
| $1.93M | ﹤0.01% |
82,390
+1,255
| +2% | +$28.1K |
|
|
AQUA
1809
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.93M | ﹤0.01% |
101,959
+1,510
| +2% | +$27.1K |
|
1810
Green Plains
GPRE
$1.06B
| $1.92M | ﹤0.01% |
124,433
+421
| +0.3% | +$5.73K |
|
|
NPKI
1811
NPK International
NPKI
$1.15B
| $1.92M | ﹤0.01% |
306,021
+12,778
| +4% | +$83.2K |
|
1812
Empire State Realty Trust
ESRT
$843M
| $1.92M | ﹤0.01% |
137,205
+9,432
| +7% | +$132K |
|
1813
American Vanguard Corp
AVD
$73.5M
| $1.91M | ﹤0.01% |
98,206
+4,935
| +5% | +$77.6K |
|
1814
ANI Pharmaceuticals
ANIP
$1.88B
| $1.91M | ﹤0.01% |
30,954
+2,217
| +8% | +$147K |
|
1815
Coherus Oncology
CHRS
$194M
| $1.91M | ﹤0.01% |
105,958
+3,753
| +4% | +$69.2K |
|
1816
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.91M | ﹤0.01% |
39,572
+656
| +2% | +$29.1K |
|
1817
Helios Technologies
HLIO
$2.72B
| $1.9M | ﹤0.01% |
41,144
+668
| +2% | +$28.7K |
|
|
RUTH
1818
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.9M | ﹤0.01% |
87,399
+3,905
| +5% | +$85.8K |
|
|
ARCH
1819
DELISTED
Arch Resources, Inc.
ARCH
| $1.9M | ﹤0.01% |
26,489
-892
| -3% | -$68.3K |
|
1820
Myers Industries
MYE
$1.32B
| $1.9M | ﹤0.01% |
113,629
+5,226
| +5% | +$86.9K |
|
1821
Kearny Financial
KRNY
$604M
| $1.89M | ﹤0.01% |
136,682
+3,797
| +3% | +$52.5K |
|
|
HT
1822
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.89M | ﹤0.01% |
129,537
+8,210
| +7% | +$116K |
|
1823
CEVA Inc
CEVA
$992M
| $1.88M | ﹤0.01% |
69,794
+3,825
| +6% | +$104K |
|
1824
Cytokinetics
CYTK
$11B
| $1.88M | ﹤0.01% |
177,227
+11,225
| +7% | +$115K |
|
1825
Acushnet Holdings
GOLF
$5.5B
| $1.87M | ﹤0.01% |
57,646
+929
| +2% | +$27.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.